Article
Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment.
Alzheimer's & dementia : the journal of the Alzheimer's Association - 1 Sept 2010
Whitehair Danielle C, Sherzai Abdullah, Emond Jennifer, Raman Rema, Aisen Paul S, Petersen Ronald C, Fleisher Adam S
Abstract excerpt
BACKGROUND: Apolipoprotein E varepsilon4 (APOE varepsilon4) allele carrier status has been well established as a risk factor for developing Alzheimer's disease. However, the specific influence of APOE varepsilon4 allele status on cognitive and functional rates of decline in mild cognitive impairment (MCI) is poorly understood. We examine the prospective association of APOE varepsilon4 allele status on measures of...
Topics
- Aged
- Aged, 80 and over
- Apolipoprotein E4
- Cholinesterase Inhibitors
- Cognition Disorders
- Disease Progression
- Donepezil
- Female
- Follow-Up Studies
- Genotype
